Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Fuji
Queensland Health
Johnson and Johnson
US Department of Justice
Deloitte
Chubb
Harvard Business School
Teva

Generated: April 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,626,566

« Back to Dashboard

Summary for Patent: 5,626,566
Title: Large dose pen
Abstract:A pen shaped syringe for repetitive injection of individually set doses of a medicine from a cylinder ampoule reservoir comprises a dose setting member which may be rotated to cause a rotative movement of a dosing member and a combined rotative and axial movement of an indicator member indicating the set dose, and a piston drive member which when rotated in one direction moves the piston into the cylinder ampoule. A unidirectional coupling is established between the dosing member and the piston drive member by each member carrying a disc having surfaces with sector shaped saw teeth riding over each other when the dosing member is rotated in the dose setting direction and engaging each other when the dosing member is rotated in the opposite direction corresponding to the direction of rotation by which the piston is moved into the cylinder ampoule. A nut/screw connection is established between a syringe housing and the dose setting member, and means are provided to release the unidirectional coupling between the piston drive member and the dosing member by drawing the coupling discs away from each other.
Inventor(s): Petersen; Lars P. K. (Gentofte, DK), Hansen; Niels-Aage B. (Havdrup, DK)
Assignee: Novo Nordisk A/S (Bagsvaerd, DK)
Application Number:08/211,131
Patent Claim Types:
see list of patent claims
Device;

Drugs Protected by US Patent 5,626,566

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,626,566

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Denmark1754/91Oct 18, 1991
PCT Information
PCT FiledSeptember 07, 1992PCT Application Number:PCT/DK92/00267
PCT Publication Date:April 29, 1993PCT Publication Number: WO93/07922

International Patents Family Members for US Patent 5,626,566

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 160946 ➤ Try a Free Trial
Australia 2795192 ➤ Try a Free Trial
Australia 662021 ➤ Try a Free Trial
Canada 2119913 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Moodys
Boehringer Ingelheim
Colorcon
McKesson
Daiichi Sankyo
Accenture
McKinsey
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.